Literature DB >> 28092348

Major molecular response prior to allogeneic hematopoietic stem cell transplantation predicts better outcome in adult Philadelphia-positive acute lymphoblastic leukemia in first remission.

W-Z Cai1, J-N Cen1, J Chen1, F Chen1,2, C-C Fu1, Y Han1, Z-M Jin1, X Ma1,2, M Miao1, H-Y Qiu1, X-W Tang1, S-L Xue1,2, A-N Sun1, S-N Chen1,2,3,4, D-P Wu1,2,3,4.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28092348     DOI： 10.1038/bmt.2016.307

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  4 in total

Review 1.  Recommendations for the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia: A consensus of North American experts.

Authors:  Nicholas J Short; Elias Jabbour; Maher Albitar; Marcos de Lima; Lia Gore; Jeffrey Jorgensen; Aaron C Logan; Jae Park; Farhad Ravandi; Bijal Shah; Jerald Radich; Hagop Kantarjian
Journal:  Am J Hematol       Date:  2018-11-26       Impact factor: 10.047

2.  Chemotherapy vs. allogeneic transplantation as post molecular remission therapy in patients aged less than 60 years with Philadelphia-positive ALL.

Authors:  Libing Wang; Juan Du; Aijie Huang; Gusheng Tang; Shenglan Gong; Hui Cheng; Weiping Zhang; Jianmin Yang; Jianmin Wang; Xiaoxia Hu
Journal:  Bone Marrow Transplant       Date:  2019-03-27       Impact factor: 5.483

3.  Measurable residual disease affects allogeneic hematopoietic cell transplantation in Ph+ ALL during both CR1 and CR2.

Authors:  Satoshi Nishiwaki; Yu Akahoshi; Shuichi Mizuta; Akihito Shinohara; Shigeki Hirabayashi; Yuma Noguchi; Takahiro Fukuda; Naoyuki Uchida; Masatsugu Tanaka; Makoto Onizuka; Yukiyasu Ozawa; Shuichi Ota; Souichi Shiratori; Yasushi Onishi; Yoshinobu Kanda; Masashi Sawa; Junji Tanaka; Yoshiko Atsuta; Shinichi Kako
Journal:  Blood Adv       Date:  2021-01-26

Review 4.  Current Approaches to Philadelphia Chromosome-Positive B-Cell Lineage Acute Lymphoblastic Leukemia: Role of Tyrosine Kinase Inhibitor and Stem Cell Transplant.

Authors:  Kunhwa Kim; Elias Jabbour; Nicholas J Short; Partow Kebriaei; Hagop Kantarjian; Farhad Ravandi
Journal:  Curr Oncol Rep       Date:  2021-06-14       Impact factor: 5.075
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.